Results 21 to 30 of about 15,332 (223)

Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait. [PDF]

PLoS ONE, 2018
Candida auris is an emerging yeast pathogen of global significance. Its multidrug-resistant nature and inadequacies of conventional identification systems pose diagnostic and therapeutic challenges. This study investigated occurrence of C.
Ziauddin Khan, Suhail Ahmad, Noura Al-Sweih, Leena Joseph, Wadha Alfouzan, Mohammad Asadzadeh   +5 more
doaj   +1 more source

Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris [PDF]

, 2017
The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable attention as a source of healthcare–associated infections. We report that this highly virulent yeast has the capacity to form antifungal resistant biofilms sensitive
Borman, Andrew, Johnson, Elizabeth M., Kean, Ryan, Ramage, Gordon, Rautemaa-Richardson, Riina, Richardson, Malcolm D., Sherry, Leighann   +6 more
core   +4 more sources

Candida auris

Nursing
Abstract: Candida auris (C. auris) is a human pathogen that can colonize the skin and various body sites without signs or symptoms or cause serious invasive infections with high mortality. The number of cases involving drug-resistant C. auris infections have increased in the US in recent years.
Jenks J, Tobin EH, Zahra F.
europepmc   +5 more sources

Comparison of Two Commercially Available qPCR Kits for the Detection of Candida auris

Journal of Fungi, 2021
Candida auris is an emerging pathogen with resistance to many commonly used antifungal agents. Infections with C. auris require rapid and reliable detection methods to initiate successful medical treatment and contain hospital outbreaks.
Janko Sattler, Janina Noster, Anne Brunke, Georg Plum, Pia Wiegel, Oliver Kurzai, Jacques F. Meis, Axel Hamprecht   +7 more
doaj   +1 more source

Surface disinfection challenges for Candida auris: an in-vitro study [PDF]

, 2018
The emerging pathogenic multidrug-resistant yeast Candida auris is an important source of healthcare-associated infections and of growing global clinical concern.
Akinbobola, A., Jones, B.L., Kean, R., MacKay, W.G., McKloud, E., Ramage, G., Sherry, L., Short, B., Townsend, E., Williams, C.   +9 more
core   +4 more sources

Persistent candidemia despite appropriate fungal therapy: First case of Candida auris from the United Arab Emirates

International Journal of Infectious Diseases, 2018
In this case, we report an elderly patient with multiple chronic conditions and prolonged intensive care unit (ICU) stays who had recurrent Candida auris (C. auris) in blood despite antifungal therapy. C.
Adnan Alatoom, Mohammad Sartawi, Karen Lawlor, Laila AbdelWareth, Jens Thomsen, Ahmad Nusair, Imran Mirza   +6 more
doaj   +1 more source

Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of Candida auris Infections

Antibiotics, 2020
Candida auris is an emerging multidrug-resistant fungal pathogen reported worldwide. Infections due to C. auris are usually nosocomial and associated with high rates of fluconazole resistance and mortality.
Mahmoud Ghannoum, Maiken Cavling Arendrup, Vishnu P. Chaturvedi, Shawn R. Lockhart, Thomas S. McCormick, Sudha Chaturvedi, Elizabeth L. Berkow, Deven Juneja, Bansidhar Tarai, Nkechi Azie, David Angulo, Thomas J. Walsh   +11 more
doaj   +1 more source

First hospital outbreak of the globally emerging Candida auris in a European hospital [PDF]

, 2016
Background: Candida auris is a globally emerging multidrug resistant fungal pathogen causing nosocomial transmission. We report an ongoing outbreak of C. auris in a London cardio-thoracic center between April 2015 and July 2016.
Abdolrasouli, A, Armstrong-James, DPH, Chowdhary, A, Fisher, MC, Hagen, F, Hall, A, Meis, JF, Rhodes, JL, Ryan, L, Schelenz, S, Shackleton, J, Trimlett, R   +11 more
core   +2 more sources

Candida auris, what do paediatricians need to know? [PDF]

, 2018
AW is supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of Aberdeen.Peer reviewedPublisher ...
Warris, Adilia
core   +1 more source

Emergence of multidrug-resistant and opportunistic fungal infections due to Candida auris in intensive care units [PDF]

Current Medical Mycology
Background and Purpose: An increasing number of invasive infections due to multidrug-resistant Candida species have been reported worldwide. Among these Candida species, Candida auris has attracted more attention in recent years due to major outbreaks in
Peetam Singh, Anita Pandey
doaj   +1 more source